SCM
OPTN

Stonepine Capital Management’s OptiNose OPTN Stock Holding History

Stonepine Capital Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-788,647
Closed -$7.23M – 77
2025
Q1 		$7.23M Buy
788,647
+199,990
+34% +$1.26M 7.04% 3
2024
Q4 		$3.93M Buy
588,657
+209,418
+55% +$1.84M 3.17% 8
2024
Q3 		$3.81M Buy
379,239
+222,572
+142% +$3.25M 2.41% 13
2024
Q2 		$2.44M Buy
+156,667
New +$2.62M 2.23% 10
2023
Q1 		– Sell
-33,886
Closed -$940K – 25
2022
Q4 		$940K Sell
33,886
-99,447
-75% -$3.78M 0.4% 19
2022
Q3 		$7.32M Sell
133,333
-41,101
-24% -$2.26M 3.29% 11
2022
Q2 		$9.58M Sell
174,434
-20,660
-11% -$760K 4.46% 8
2022
Q1 		$7.23M Sell
195,094
-61,188
-24% -$2.18M 3% 13
2021
Q4 		$6.23M Buy
+256,282
New +$8.58M 2.86% 11

Stonepine Capital Management's OPTN Position: Q2 2025 in Review

Stonepine Capital Management sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 788,647 shares — an estimated $7.23M sold.

Stonepine Capital Management first reported a position in OPTN in Q4 2021 and held it in 9 quarters. The position peaked at $9.58M in Q2 2022. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

  • Stonepine Capital Management reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 788,647 OptiNose shares in Q2 2025, an estimated $7.23M.
  • Stonepine Capital Management first reported a position in OptiNose in Q4 2021 and held it in 9 quarters.
  • Stonepine Capital Management's OptiNose position peaked at $9.58M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.